respectively. However, when thiols (cysteine and homocysteine) that are disulfide bonded to albumin-Cys 34 are removed by treatment with dithiothreitol to form albumin-Cys 34 -SH
INTRODUCTION
Hyperhomocysteinemia is a modifiable, independent, and graded risk factor for cardiovascular disease (1) (2) (3) , and an emerging risk factor for cognitive dysfunction and Alzheimer's disease (4) (5) (6) . In healthy individuals plasma total homocysteine (tHcy) 1 concentrations range from 5-12 µM, and > 98% of tHcy is in a disulfide form (7) . Protein-disulfide-bound homocysteine accounts for > 70% of tHcy, and the remaining homocysteine is found as free low molecular weight disulfide forms including homocystine and homocysteine-cysteine mixed disulfide (HCMD) (8) . Less than 2% of tHcy in circulation exists in the free reduced sulfhydryl (-SH) form (8) . In addition a small amount of homocysteine (∼10% tHcy) may be present as "homocystamide", the reaction product formed between homocysteine thiolactone and protein lysine residues (9) .
It is generally assumed that homocysteine is exported from cells into circulation in the free reduced sulfhydryl form due to the low redox potential of the intracellular milieu. However, there are few detailed mechanistic studies on the formation of the disulfide forms of homocysteine in circulation. It has been reported that ceruloplasmin catalyzes the autooxidation of cysteine to cystine (10) and the autooxidation of homocysteine to homocystine with the Homocysteine and Cysteine Disulfides in Circulation 5 homocysteine by 20 to 30 fold, and although it undergoes similar oxidative chemistry cysteine is usually not considered a risk factor for cardiovascular disease (17) .
We recently demonstrated that HCMD is preferentially formed when homocysteine reacts with albumin-Cys 34 -S-S-Cys (albumin-bound cysteine) (18) . The other product of the reaction, albumin-Cys 34 -S -(albumin thiolate anion) then reacts with either HCMD or homocystine to form albumin-Cys 34 -S-S-Hcy (albumin-bound homocysteine). This reaction, which occurs by thiol/disulfide exchange, mechanistically accounts for the formation of albumin-bound homocysteine, the major form of homocysteine in circulation (18) . These observations led us to hypothesize that albumin could play a critical role in the formation of homocystine and other low molecular weight disulfide forms of homocysteine as well. In the current report, we provide evidence showing that albumin drives homocysteine chemistry in circulation largely through thiol/disulfide exchange mechanisms, whereas ceruloplasmin drives cysteine chemistry largely through oxidative mechanisms. This study proposes a unified mechanism to account for the formation of the circulating forms of cysteine and homocysteine. A better understanding of the thiol/disulfide exchange chemistry of homocysteine and its disulfide forms may provide insight into the true atherothrombogenic potential of this important risk factor for vascular disease.
Preparation of ceruloplasmin-depleted plasma. Ceruloplasmin was immunoprecipitated from
human plasma by treatment with rabbit anti-human ceruloplasmin antiserum for 2 h at room temperature in 0.05 M TES buffer (pH 7.3) followed by incubation with protein G-agarose for 2 h in the same buffer and centrifugation. The ceruloplasmin-deficient supernatant was concentrated by ultrafiltration using Centricon-10 filters (Amicon, Beverly, MA) and stored at -20°C. Control plasma was treated in the same manner, except that the anti-ceruloplasmin antibody was omitted.
Complete removal of the ceruloplasmin was verified by SDS-PAGE on a 4-12% polyacrylamide gel (24) followed by western blotting with rabbit anti-human ceruloplasmin antiserum.
Preparation of albumin-deficient plasma. Albumin was removed from human plasma by affinity chromatography (25) using Cibacron-blue agarose (Sigma Chemical Co.) that was equilibrated with 0.05 M Tris-HCl containing 0.5 M NaCl (pH 8.0). Human plasma was applied to the column and fractions were collected until the absorbance (A 280 ) was less than 0.1. Bound albumin was then eluted from the column with the same buffer containing 0.2 M NaSCN. Both the albumin-deficient fraction and the albumin-rich fraction were concentrated by freeze-drying, redissolved in 0.05 M TES buffer (pH 7.3) and dialyzed against the same buffer to remove residual NaSCN. Protein concentrations in the two fractions were determined by bicinchoninic acid method (26) .
Oxidation of biological thiols with copper.
A dose-dependent study on the ability of CuSO 4 to catalyze the autooxidation of 500 µM L-homocysteine was carried out by monitoring the levels of homocysteine remaining in the reaction mixture with DTNB. Additional oxidation studies on cysteine, cysteinylglycine, glutathione and homocysteine were carried out by incubating 500 µM solutions of either thiol with 25 µM CuSO 4 in 0.05 M TES buffer (pH 7.3). Aliquots (0.05 ml)
were withdrawn at various time points and added directly to tubes containing DTNB reagent (22) .
The amount of free thiol remaining was calculated using a molar extinction coefficient of 13,600
at 412 nm.
Oxidation of biological thiols with human serum albumin, human plasma and ceruloplasmin.
The DTNB method for determining sulfhydryl compounds is unreliable in solutions containing protein. For this reason a HPLC method using the sulfhydryl specific reagent monobromobimane was employed (19) . Solutions (500 µM) of L-homocysteine, L-cysteine, cysteinylglycine or glutathione were incubated with either human plasma or physiological concentrations of human serum albumin or ceruloplasmin in 0.05 M TES buffer (pH 7.3) for different time periods.
Aliquots of the sample were withdrawn and directly added to tubes containing 7.0 mM monobromobimane in 4.0 mM EDTA (pH 7.0). The tubes were incubated at 42°C for 12 min, allowed to cool to room temperature for 20 min, and then 0.025 ml of 1.5 M perchloric acid was added. The tubes were incubated on ice for 10 min and centrifuged at 14,000 rpm to pellet precipitated protein. The supernatant was then adjusted to pH 4.0 by addition of 0.006 ml of 2.0 M Trizma ® base. Samples (0.10 ml) were transferred to injector vials for the determination of thiols by HPLC-FD as described by Jacobsen et al. (19) . Standard curves were generated with known amounts of L-homocysteine, L-cysteine, cysteinylglycine and glutathione to calculate the concentrations of the two thiols in the reaction mixtures. The same protocol was used to study the oxidation of homocysteine by albumin thiolate anion, human plasma, ceruloplasmin-depleted human plasma and albumin-deficient human plasma.
For experiments designed to study the effect of protein-bound transition metals on the oxidation of thiols human plasma, ceruloplasmin-depleted human plasma, or human serum albumin, were incubated with 5.0 mM DTPA for 3 h in 0.05 M TES buffer (pH 7.3) at 25°C and then dialyzed exhaustively. Control plasma, albumin, or ceruloplasmin-depleted plasma (without the addition of DTPA) were processed similarly. The protein preparations were then incubated with biological thiols, and the amounts of free thiol remaining in the reaction mixtures were determined by HPLC-FD as described above. Statistical analysis. P values were calculated with Quatro Pro for Windows using a two tailed student's T test. Differences were considered significant when P <0.05.
Determination of albumin-bound homocysteine (albumin-Cys

RESULTS
Role of copper in the formation of homocystine. We recently reported that albumin-Cys 34 thiolate anion plays an essential role in the formation of albumin-bound homocysteine (18) .
During this study we obtained evidence indicating that purified human albumin played a role in the conversion of homocysteine to its low molecular weight disulfide forms by a mechanism that involved thiol/disulfide exchange. When 750 µM human serum albumin was incubated with 500
µM L-homocysteine, little or no L-homocysteine could be detected after 3 h (Fig. 1) . The fate of the L-homocysteine was determined by product analysis after 3 h. Of the initial 500 µM Lhomocysteine in the reaction mixture, only 170 µM was bound to albumin (Fig. 1) . The remaining 330 µM homocysteine was converted into its low molecular weight disulfides, HCMD (90 µM) and homocystine (240 µM) (18) . However, in the absence of albumin, the Lhomocysteine concentration remained essentially unchanged after 3 h (data not shown). Because a previous report showed that copper catalyzed the autooxidation of homocysteine (11), we determined the amount of copper in our purified albumin preparation and buffer solutions using ICPMS ( Table 1 ). The purified albumin used in these experiments contained 2.9 µM copper per 750 µM albumin, while the buffer used was essentially copper free.
To determine if the copper associated with our purified albumin preparation was sufficient to catalyze the oxidation of L-homocysteine, we incubated 500 µM L-homocysteine with various concentrations of cupric sulfate. As shown in Fig. 2 , free Cu +2 catalyzes the oxidation of homocysteine in a dose-dependent manner. However, the conversion of L-homocysteine to Lhomocystine by 3 µM free Cu +2 (equivalent to the concentration of copper in the albumin preparation used above) was less than 10% of that seen with albumin ( Fig ) were even less efficient in catalyzing homocysteine autooxidation (data not shown) and were not considered for further study.
Autooxidation of biological thiols by Cu
+2
. We determined the relative ability of free Cu 3D ) was considerably slower than that of L-cysteine and cysteinylglycine, but faster than that observed for L-homocysteine. Thus, although Cu +2 catalyzes the autooxidation of all four thiols, the rate of autooxidation is fastest for cysteine and cysteinylglycine followed by glutathione and then L-homocysteine. In the absence of Cu +2 (buffer only), there was no appreciable oxidation (< 1%) of the four thiols over the 5 h time course.
Autooxidation of biological thiols by ceruloplasmin.
In circulation 90-95% of the copper is bound to the copper-binding protein ceruloplasmin (27) . Most of the remaining copper is bound to albumin with little or no copper existing in the free form. Since it has been shown that ceruloplasmin catalyzes thiol oxidation (10,11), we repeated the above experiments with the four thiols (all at 500 µM final concentration) using a physiological concentration of ceruloplasmin (300 µg/ml) in place of cupric sulfate. As shown in Fig Role of albumin in homocysteine disulfide formation. Albumin is known to carry 5-10% of the total copper in circulation (28) . The 20% inhibition of homocysteine oxidation by DTPA-treated plasma observed in the previous experiment (Fig. 5 ) could have been due to the chelation and removal of copper from albumin. To study the relative abilities of albumin and ceruloplasmin to mediate the conversion of homocysteine to homocystine, we initiated the oxidation of Lhomocysteine with 300 µg/ml ceruloplasmin as shown in Fig. 6A . At 2 h albumin was added and this triggered a dramatic increase in the rate of conversion of homocysteine to its disulfide forms (Fig. 6A ). It should be noted that the concentrations of ceruloplasmin and albumin used in this experiment are physiological. The conversion of homocysteine to its disulfide forms was then studied using concentrations of albumin from 15 to 750 µM. As shown in Fig. 6B , the extent of conversion of homocysteine to its disulfide forms increases with increasing concentrations of albumin up to 600 µM after which the process appears to saturate.
To determine if other proteins in plasma apart from albumin played any significant role in the oxidation of homocysteine, albumin was separated from human plasma by affinity chromatography as described in the experimental procedures. Both the albumin-deficient plasma and the albumin-rich fraction obtained after affinity chromatography were incubated with 500 µM L-homocysteine for 2 h. The albumin-rich fraction (final protein concentration was 15 mg/ml) catalyzed the oxidation of homocysteine much more efficiently than an equivalent protein concentration of the albumin-deficient plasma (Fig. 7) .
The data shown in Figs. 5-7 suggest that the copper associated with albumin in plasma might be responsible for approximately 20% of the overall conversion of homocysteine to homocystine.
To investigate if the copper associated with albumin is responsible for homocysteine autooxidation, we treated albumin with the metal chelator DTPA. After treatment of albumin with DTPA and dialysis, > 97% of the copper associated with albumin was removed as determined by ICPMS (Table 1) . DTPA treatment also removed > 97% of other metals present in the albumin preparation (data not shown). The conversion of homocysteine to its disulfides was
inhibited by approximately 20% with DTPA-treated albumin as compared to the native albumin ( Fig. 8A ), similar to that observed with DTPA-treated plasma (Fig. 5 ). This indicates that copperdependent autooxidation of homocysteine is a minor pathway in the overall conversion to disulfide forms and that thiol/disulfide exchange reactions are much more important. However, the oxidation of cysteine (Fig. 8B) and cysteinylglycine (Fig. 8C ) by copper-free albumin was inhibited by more than 50% within the first 15 min of the reactions. In addition, the rates of cysteine and cysteinylglycine oxidation in the presence of native albumin were faster than that of homocysteine. These results are consistent with the data shown in Figs. 3 and 4 where both free and ceruloplasmin-bound copper catalyzed the autooxidation of cysteine and cysteinylglycine much faster than the autooxidation of homocysteine. The rate of conversion of glutathione to its oxidized forms by albumin and copper-free albumin (Fig. 8D ) was slower than that observed for homocysteine (Fig. 8A ). However, it should be noted that the albumin-mediated conversion rates of glutathione (Fig. 8D ) are faster than those observed for free copper (Fig. 3D ) and ceruloplasmin (Fig. 4D) .
Albumin thiolate anion. The conversion of albumin to albumin thiolate anion (mercaptalbumin)
by treatment with 5 molar excess DTT resulted in an albumin preparation that was completely inactive with respect to converting homocysteine to its disulfide forms (Fig. 9A ). This preparation also failed to convert cysteine to its disulfide form (Fig. 9B) catalysts and molecular oxygen (10, 31, 32) , and this process leads to the formation of reactive oxygen species such as hydrogen peroxide and superoxide anion radical. It is generally assumed that homocysteine, being a thiol compound, undergoes similar autooxidative chemistry (11).
However, the plausibility of the homocysteine autooxidation hypothesis and cellular damage induced by reactive oxygen species has been questioned recently (17, 33, 34 ).
An alternative hypothesis is that homocysteine attacks specific molecular targets, which results in the modification of their structure and function. Examples of the "molecular target hypothesis"
include inhibition of endothelial cell proliferation by the homocysteine metabolite S- The principal low molecular weight disulfide forms of homocysteine in circulation are homocystine and HCMD. We previously showed that HCMD is formed by a thiol/disulfide exchange reaction between homocysteine and albumin-Cys 34 -S-S-cysteine (18) . In the present study, we further show that the role of copper-catalyzed or ceruloplasmin-catalyzed autooxidation of homocysteine is probably only a minor process in circulation. Starkebaum and Harlan (11) earlier reported that homocysteine is efficiently autooxidized by both copper and ceruloplasmin in vitro and that the autooxidation resulted in the generation of hydrogen peroxide.
However, we find that both the rate of copper and ceruloplasmin mediated autooxidation of homocysteine is much slower than previously reported. In circulation ceruloplasmin is present at a concentration of ~300 µg/ml (2.3 µM) and is known to bind 7 copper atoms per protein molecule. Hence, the concentration of ceruloplasmin bound copper is about 16 µM. However, only the copper atom bound to His 426 of ceruloplasmin is known to be catalytically active in autooxidation reactions (40) . Thus, in effect 300 µg/ml ceruloplasmin has only 2.3 µM copper available for oxidation reactions. In studies using free cupric ion we found that 2.5µM copper did not catalyze the autooxidation of homocysteine to any appreciable extent (Fig. 2) , and when ceruloplasmin was immunoprecipitated from human plasma, the ability of plasma to mediate the conversion of L-homocysteine to its disulfide forms was unaltered. Thus, ceruloplasmin is probably not an important physiological catalyst for the autooxidation of L-homocysteine.
Moreover, the treatment of both control plasma and ceruloplasmin-depleted plasma with DTPA resulted in only a 20% inhibition of L-homocysteine autooxidation, suggesting that the small amount of copper bound to albumin plays a greater role in homocysteine autooxidation than the copper bound to ceruloplasmin. Cupric ion and ceruloplasmin, however, were found to be highly (Fig. 4) . Whether this is largely due to differences in the sulfhydryl pKa's or to the structural differences of the molecules and their ability to interact with copper at His 426 of ceruloplasmin will require further study.
Albumin mediated the conversion of L-homocysteine to HCMD, L-homocystine and albuminbound homocysteine in a dose-dependent manner. Albumin-deficient plasma was significantly less efficient in mediating the conversion of L-homocysteine to its disulfide forms (Fig.7) . These results suggest that in plasma albumin is primarily responsible for these reactions and is consistent with the observations of Joyce (48) who reported that albumin but not ceruloplasmin is responsible for the oxidation of penicillamine, a thiol-containing drug.
Normal plasma total copper ranges from 11 to 25 µM, and up to 30 µM in individuals over 60 years of age (49) . About 10% of the copper in circulation is bound to His 3 of albumin (50) . The albumin used in these experiments contained 2.9 µM copper as determined by ICPMS (Table 1) .
Removing this copper inhibited the overall conversion of L-homocysteine to its disulfide forms by 20% (Fig. 8A) , suggesting that albumin-bound copper mediates only about one-fifth of the overall conversion of homocysteine to its disulfide forms, while 80% is mediated through albumin by thiol/disulfide exchange. However, the removal of copper from albumin inhibited the oxidation of L-cysteine and cysteinylglycine by more than 50% during the initial phase of the reaction suggesting that copper is much more important for the autooxidation of cysteine and cysteinylglycine than it is for the autooxidation of homocysteine. Although the removal of copper from albumin caused only a 20% reduction in the conversion of L-homocysteine to its disulfide forms, the stripping of cysteine and other thiol ligands from Cys 34 as well as removal of copper from His 3 by treatment of albumin with DTT resulted in the complete inactivation of albumin to mediate these processes. Thus, albumin thiolate anion (mercaptalbumin), devoid of sulfur amino acid ligands at Cys 34 and copper at His 3 , does not react with either homocysteine or cysteine.
The rate of conversion of glutathione to its disulfide forms is faster with physiological concentrations of albumin than it is with physiological concentrations of free copper or ceruloplasmin. Oxidized glutathione could also be produced by glutathione peroxidase in circulation, further complicating a mechanistic understanding. Thus, oxidation could proceed along both enzymic and non-enzymic mediated pathways.
In circulation albumin carries disulfide-bonded cysteine and glutathione at Cys 34 (50) and is probably the major carrier of homocysteine as well (18, 51) . The question then is, if albumin thiolate anion, the form secreted into circulation by the liver (50), is not capable of interacting with reduced thiols as discussed above, how do they become disulfide bonded to albumin-Cys Our model is consistent with clinical studies of plasma thiols (52, 53) . After intravenous injection of homocysteine into healthy individuals, tHcy rapidly increases while protein-bound cysteine decresed. This suggests that homocysteine preferentially targets protein-bound cysteine rather than undergoing autooxidative reactions (52) . The model is also consistent with the data from patients with homocystinuria due to homozygous cystathionine β-synthase deficiency. In these patients tHcy can exceed 400 µM, with up to 20% present in the form of free reduced homocysteine (53) . Our model would predict that in the presence of high free reduced homocysteine, the concentration of plasma protein-bound cysteine should be low while proteinbound homocysteine should be high. This is exactly the situation found in these patients (53) .
Not only is protein-bound cysteine low but protein-bound cysteinylglycine is low as well. The free oxidized forms of homocysteine, presumably consisting of homocystine and HCMD (individual species were not determined) are also elevated (53), as our model would predict. The high level of free reduced homocysteine found in homocystinuric patients, up to 20% of tHcy, is markedly higher than that found in normal or mildly hyperhomocysteinemic individuals whose free reduced homocysteine concentration is < 2% of tHcy. It has also been reported that the concentrations of copper and ceruloplasmin are elevated in patients with homocystinuria (54, 55) .
Thus, if copper is responsible for the oxidation of homocysteine in vivo, then homocystinuric patients would be expected to have very low concentrations of free reduced homocysteine due to the excess copper in their circulation. However, the concentration of free reduced homocysteine in plasma from homocystinuric patients is up to 500-1000 times higher than normal, consistent with our data indicating that copper and/or ceruloplasmin do not play major roles in homocysteine autooxidation.
It is widely believed that homocysteine may be harmful due to the generation of extracellular reactive oxygen species produced during its autooxidation by transition metal ions. Herein, however, we show that most of the homocysteine in circulation is probably converted to low molecular weight disulfides through thiol/disulfide exchange reactions rather than through direct autooxidation. Furthermore, if autooxidation and the subsequent formation of reactive oxygen Data represent the mean ± SD (n = 3). P <0.05. 
